New Edge Advisors, LLC United Therapeutics Corp Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, New Edge Advisors, LLC holds 3,027 shares of UTHR stock, worth $860,424. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,027
Previous 1,348
124.55%
Holding current value
$860,424
Previous $483,000
121.12%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding UTHR
# of Institutions
729Shares Held
40.7MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.26 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$785 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$625 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$594 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $12.9B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...